Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |